Rufen Sie uns an: +49 1702428058
ANTI-INFECTIVES An R&D Focus
With years upon years of first-hand experience in advancing the development of the modern medicine and drugs, we know how to make the world healthier!
ReHealth’s development efforts in anti-infectives are focused on bringing forward treatments for difficult to treat infections. Lead programs include Ceftazidime/Avibactam, a potential treatment for hospital acquired bacteria pneumonia/ventilator acquired bacterial pneumonia, as well as Aztreonam/Avibactam, a novel treatment for gram-negative infections. ReHealth is also focused on adding new innovative programs throughout its seven therapeutic areas.
Here's how it works:
1
ReHealth’s development efforts in anti-infectives are focused on bringing forward treatments for difficult to treat infections.
2
Lead programs include Ceftazidime/Avibactam, a potential treatment for hospital acquired bacteria pneumonia/ventilator acquired bacterial pneumonia.
3
Also we focus on Aztreonam/Avibactam, a novel treatment for gram-negative infections. ReHealth is also focused on adding new innovative programs throughout its seven therapeutic areas.
Apply for a Job with Us!
Each year we’ve got a lot of miscellaneous job offerings. See which ones are right for you!